Literature DB >> 12869396

Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers.

Gary J Kelloff1, Joyce A O'Shaughnessy, Gary B Gordon, Ernest T Hawk, Caroline C Sigman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12869396

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  3 in total

1.  The effectiveness of chemoprevention agents is underestimated when lesion sizes are rounded.

Authors:  Thomas H Taylor; William B Armstrong; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-19

2.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

Review 3.  Mitochondrial and nuclear genomics and the emergence of personalized medicine.

Authors:  Ryan L Parr; Luis H Martin
Journal:  Hum Genomics       Date:  2012-07-05       Impact factor: 4.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.